Activation of different split functionalities on re-association of RNA-DNA hybrids

被引：0

作者：

Afonin K.A. ^{[1
]}

Viard M. ^{[1
,2
]}

Martins A.N. ^{[3
]}

Lockett S.J. ^{[4
]}

MacIag A.E. ^{[2
,5
]}

Freed E.O. ^{[3
]}

Heldman E. ^{[2
,6
]}

Jaeger L. ^{[7
]}

Blumenthal R. ^{[1
]}

Shapiro B.A. ^{[1
]}

机构：

[1] Center for Cancer Research Nanobiology Program, NCI, Frederick

[2] Basic Science Program, SAIC-Frederick, Frederick National Laboratory for Cancer Research, Frederick

[3] HIV Drug Resistance Program, NCI, Frederick

[4] Advanced Technology Program, SAIC-Frederick, Frederick National Laboratory for Cancer Research, Frederick

[5] Chemical Biology Laboratory, NCI, Frederick

[6] Ben-Gurion University of the Negev, Beer Sheva

[7] Department of Chemistry and Biochemistry, Biomolecular Science and Engineering Program, University of California, Santa Barbara

来源：

Nature Nanotechnology | 2013年 / 8卷 / 4期

关键词：

D O I：

10.1038/nnano.2013.44

中图分类号：

学科分类号：

摘要：

Split-protein systems, an approach that relies on fragmentation of proteins with their further conditional re-association to form functional complexes, are increasingly used for various biomedical applications. This approach offers tight control of protein functions and improved detection sensitivity. Here we report a similar technique based on a pair of RNA-DNA hybrids that can be used generally for triggering different split functionalities. Individually, each hybrid is inactive but when two cognate hybrids re-associate, different functionalities are triggered inside mammalian cells. As a proof of concept, this work mainly focuses on the activation of RNA interference. However, the release of other functionalities (such as resonance energy transfer and RNA aptamer) is also shown. Furthermore, in vivo studies demonstrate a significant uptake of the hybrids by tumours together with specific gene silencing. This split-functionality approach presents a new route in the development of 'smart' nucleic acid-based nanoparticles and switches for various biomedical applications. Copyright © 2013 Macmillan Publishers Limited. All rights reserved.

引用

页码：296 / 304

页数：8

共 50 条

[1] Johnsson N., Varshavsky A., Split ubiquitin as a sensor of protein interactions in vivo, Proc. Natl Acad. Sci. USA, 91, pp. 10340-10344, (1994)
[2] Cassonnet P., Et al., Benchmarking a luciferase complementation assay for detecting protein complexes, Nature Methods, 8, pp. 990-992, (2011)
[3] Shekhawat S.S., Ghosh I., Split-protein systems: Beyond binary protein-protein interactions, Curr. Opin. Chem. Biol., 15, pp. 789-797, (2011)
[4] Guo P., The emerging field of RNA nanotechnology, Nature Nanotech., 5, pp. 833-842, (2010)
[5] Pecot C.V., Calin G.A., Coleman R.L., Lopez-Berestein G., Sood A.K., RNA interference in the clinic: Challenges and future directions, Nature Rev. Cancer, 11, pp. 59-67, (2011)
[6] Davis M.E., The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: From concept to clinic, Mol. Pharm., 6, pp. 659-668, (2009)
[7] Shukla G.C., Et al., A boost for the emerging field of RNA nanotechnology, ACS Nano, 5, pp. 3405-3418, (2011)
[8] Afonin K.A., Et al., Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine, Nature Protoc., 6, pp. 2022-2034, (2011)
[9] Shu Y., Cinier M., Shu D., Guo P., Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells, Methods, 54, pp. 204-214, (2011)
[10] Davis M.E., Et al., Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles, Nature, 464, pp. 1067-1070, (2010)

← 1 2 3 4 5 →